Smith & Nephew plc (NYSE:SNN) Shares Acquired by Wells Fargo & Company MN

Wells Fargo & Company MN lifted its stake in shares of Smith & Nephew plc (NYSE:SNNFree Report) by 20.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,003,050 shares of the medical equipment provider’s stock after acquiring an additional 173,448 shares during the period. Wells Fargo & Company MN owned 0.23% of Smith & Nephew worth $27,363,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. CWM LLC lifted its position in Smith & Nephew by 68.6% during the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 388 shares during the period. Spire Wealth Management lifted its position in Smith & Nephew by 224.3% during the fourth quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 702 shares during the period. Allworth Financial LP lifted its position in Smith & Nephew by 65.8% during the fourth quarter. Allworth Financial LP now owns 1,878 shares of the medical equipment provider’s stock worth $51,000 after buying an additional 745 shares during the period. Principal Securities Inc. purchased a new position in Smith & Nephew during the fourth quarter worth about $52,000. Finally, GAMMA Investing LLC purchased a new position in Smith & Nephew during the fourth quarter worth about $53,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Price Performance

Smith & Nephew stock opened at $24.90 on Wednesday. The stock’s 50-day moving average is $24.91 and its 200-day moving average is $26.34. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.72 and a current ratio of 1.77. Smith & Nephew plc has a 12 month low of $21.52 and a 12 month high of $32.28.

Smith & Nephew Announces Dividend

The company also recently disclosed a semi-annual dividend, which was paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd were issued a $0.462 dividend. The ex-dividend date of this dividend was Monday, April 1st. This represents a dividend yield of 2.8%.

Analyst Ratings Changes

Separately, StockNews.com downgraded Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Monday, May 13th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Smith & Nephew currently has an average rating of “Moderate Buy”.

Check Out Our Latest Analysis on SNN

About Smith & Nephew

(Free Report)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Further Reading

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNNFree Report).

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.